Tech Company Financing Transactions
MD Ally Funding Round
MD Ally, based in New York, secured $14 million from Frist Cressey Venture, General Catalyst and Alumni Ventures.
Transaction Overview
Company Name
Announced On
8/13/2024
Transaction Type
Venture Equity
Amount
$14,000,000
Round
Series A
Investors
Frist Cressey Venture (Lead Investor)
General Catalyst (Lead Investor)
Proceeds Purpose
The company intends to use the funds to further enhance its 911 and EMS-integrated technology, expand clinical services, and extend downstream care coordination partnerships.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
300 W 57th St.
New York, NY 10019
USA
New York, NY 10019
USA
Phone
Website
Email Address
Overview
MD Ally was designed to enable an innovative EMS-provider collaboration that optimizes community-based medical services, establishes strong patient-provider relationships, and ensures great clinical and financial outcomes for the patient.
Management Team
Browse more venture capital transactions:
Prev: 8/13/2024: Pelage Pharmaceuticals venture capital transaction
Next: 8/13/2024: NewBold venture capital transaction
Share this article
News on VC Transactions
We report on every notable VC transaction. VC transactions reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs